This site uses cookies. By using this site you agree to receiving cookies. View Policy.
/https://files-crowdcube-com.s3.amazonaws.com/company_images/4178/201609/2a646fa4746ca2230fc1ecb39a1693a5.jpg "Celixir")
Celixir (previously trading as Cell Therapy) is a British pioneer in Regenerative Medicine. Its team of scientists and biotechnology leadership is devoted to discovering breakthrough medicines that aim to change the standard of medical care for patients.
-
Amount raised (£)
£689,246
-
Company number
06970743
-
Incorporation date
23/07/2009
-
Total investors
297
News
View all news| More financial returns for Crowdcube investors as biotech company Celixir delivers 2.7x return with share buy-back Angel News Newsletter |
12/04/2017 |
| Crowdcube Success Cell Therapy Receives £12.5M in Japan Rights Deal Crowdfund Insider |
10/05/2016 |
| Crowdcube Success Cell Therapy Receives £12.5M in Japan Rights Deal Crowdfund Insider |
10/05/2016 |
| Cell Therapy eyes initial public offering Media Wix |
04/10/2015 |
Online presence
Details
-
Company number
06970743
-
Incorporation date
23/07/2009
-
Company status
Active
-
Industry type
Other research and experimental development on natural sciences and engineering
-
Number of current appointments
3
Location
View on Google Maps
Celixir House Stratford-Upon-Avon Business & Technology Park
Innovation Way
Stratford-Upon-Avon
CV37 7GZ
Innovation Way
Stratford-Upon-Avon
CV37 7GZ
Crowdcube Funding History
| Date | Amount | No. of Investors | |
|---|---|---|---|
| 01/12/2014 | £689,246 | 297 | View |
Key Financials
View all financials| 2018 | 2019 | |
|---|---|---|
| Turnover | £715.38k | £765.11k |
| Cash | £5.23m | £1.79m |
| Increase in Cash | - | - |
Financial data drawn from last filed accounts don't necessarily reflect current trading activity.
Documents
More documents on Companies HousePeople
| Name | Role | Appointed | Nationality |
|---|---|---|---|
| EVANS, Martin John, Sir | Director | 09/07/2009 | British |
| REGINALD, Trevor Ajan | Director | 12/06/2012 | British |
| CELIXIR PLC | Corporate-director | 19/01/2019 |
